By DRCNet Foundation & Associazone Luca Coscioni

Side event at the 51st Session of the UN Human Rights Council, Geneva

 Tuesday 4 October 2022 / 3-4pm CET / 9-10pm PHT / 9-10am ET

: https://us02web.zoom.us/meeting/register/tZMocOyupj4qE9INDq4OqGL71jsyyRFjvVIQ

Last 24 February, Senator Leila de Lima marked five years of incarceration in the Philippines. Under the administration of recently-elected President Ferdinand Marcos Jr., de Lima remains jailed, despite not being convicted of a crime, and despite the recantations of three key accusers, who say they provided testimony because of pressure.

In the meanwhile, the extrajudicial killing campaign begun by former President Rodrigo Duterte continues. The Office of the Prosecutor (OTP) of the International Criminal Court, after pausing its investigation because of a Duterte administration treaty motion for reconsideration, has sought the court's authorization to resume it. But the Marcos administration has rejected the ICC investigation and said it will not cooperate.

In "The Continuing Detention of Senator Leila de Lima," speakers will review her case, and the larger human rights situation in the Philippines.

Senator Risa Hontiveros, Republic of the Philippines (prerecorded video)

Marco Perduca, Associazone Luca Coscioni and former Senator, Italy

David Borden, Executive Director, DRCNet Foundation AKA StoptheDrugWar.org

Human rights in the Philippines: The continuing detention of Senator Leila de Lima

CND Chair one-day special forum on availability and access to controlled substances for medical and scientific purposes.

: 10 October, 10.30 a.m. Vienna time (CET)

: BR-B, M-Building, Vienna International Centre and online

The 2022 National Harm Reduction Conference comes at a time when harm reduction, health care, and drug policy reform have entered a dynamic and critical phase. The prescription opioid and heroin overdose epidemic has captured national attention, with renewed focus on transmission of HIV and viral hepatitis among people who use drugs. These trends are reshaping the policy and public health landscapes, making harm reduction more urgent and relevant than ever before.

The biennial event is the only conference of its kind in the United States. For four days, some of the most creative minds from the U.S. and abroad come together to address a myriad of complex issues facing the harm reduction movement. A diverse community of people who use drugs, social justice activists, service providers, healthcare workers, researchers, policymakers, public health officials, and law enforcement— all coming together to put an end to the harms and injustices caused by the War on Drugs.

Providing safe spaces for the exchange of ideas and cutting-edge practices that reduce harms associated with drug use

Creating networking opportunities for people from diverse backgrounds committed to dismantling the racialized policies that underwrite and perpetuate oppression

Challenging stigmatizing narratives about people who use drugs by supporting their leadership development and exposing social inequities driven by structural violence and discrimination

In addition to workshops, roundtable discussions, plenaries, poster presentations, and an exhibit hall, other conference highlights include:

The Imani P. Woods Award for Excellence in Harm Reduction Activism

Wellness Space (yoga, mindfulness, meditation, affinity group meetings, and more)

The National Harm Reduction Conference registration will start at 9:00am, Thursday October 13th with the Opening Session starting promptly at 10:00am. The Closing Session will begin at 11:00am on Sunday, October 16th and end at 1:00pm.

All event times use Puerto Rico local time (GMT-4).

13th US National Harm Reduction Conference

The 10th International Conference on Health and Hepatitis Care in Substance Users will take place at Glasgow's Scottish Event Campus on 19-21 October 2021.

Abstracts and scholarship applications will open in January 2022

Scholarship Applications Close: 20 March 2022

Late Breaker Abstracts Close: 5 June 2022

Early Bird Registrations Close: 31 July 2022

Standard Registration Close: 18 September 2022

Network in-person with a global community of people dedicated to improving the health of people who use drugs

Attend in-person or online, with access to digital sessions up to three months after the conference has ended

Over 100 sessions on the topic of drug policy, health and wellbeing of people who use drugs, harm reduction, hepatitis C and other infectious diseases

Join various special interest sessions including nurses, early to mid-career researchers, prisons, community and more

10th International Conference on Health and Hepatitis Care in Substance Users

 21 October 2022 / 9:00 am - 11:00 am EDT

On the sidelines of the 77th session of the United Nations General Assembly (UNGA), and following the presentation of 

, to UNGA, the Lancet Medical Journal and the O’Neill Institute for National and Global Health at Georgetown University will be announcing their 

Commission on Racism, Structural Discrimination and Global Health

. This three-year commission will bring together experts from across the globe to uncover and promote anti-racist strategies and actions to reduce barriers to health and wellbeing facing communities on the basis of race, ethnicity, tribe, caste, gender identity or expression, sexual orientation, disability, or religion.

We invite you to join us Friday, October 21, 2022 from 9:00 – 10:30 AM EST for a panel discussion on accurately diagnosing the problem of racism in global health.

The work of the commission is rooted in the recognition that racism, rather than race, creates and maintains unjust and avoidable health inequities in countries around the world. Racial and ethnic disparities in health outcomes are increasingly recognized worldwide, and the commission starts from the premise that the impact of racism inside and outside the health sector is a driver of health inequity that has not been sufficiently understood and addressed as a phenomenon that spans borders.

“The COVID-19 pandemic has dramatically highlighted the urgency of addressing racism directly when it comes to health,” said Dr. Tlaleng Mofokeng, co-chair of the commission. “It has also raised critical questions about the continuing colonial relationships undergirding global health efforts. Now is the time to confront this reality and accept that too little progress has been achieved to reduce discrimination in health.”

To attend this event virtually or in-person at the Ford Foundation Center for Social Justice in New York City (320 E 43rd St, New York, NY 10017), please register 

Advancing health equity: Time to address racism and structural discrimination in global health

The Centre for Research and Information on Substance Abuse (CRISA) hereby announces its 14th Biennial International Conference on Drugs, Alcohol and Society in Africa. The conference will hold in Abuja on 26 and 27 October 2022. In the context of a growing demand for the modernization of the international drug control system, the major theme of the 2022 conference is “Towards the Reform of Drug Law and Policy in Africa: Research, Practice and Advocacy Considerations”.

We invite you to submit abstracts of policy relevant research papers on this theme for presentation at the conference. We will also consider requests to organize panel discussions, debates and workshops on the topic of drug and alcohol policy in one country, region or across the continent. We welcome original contributions from a range of disciplines, including health and social sciences, law, the humanities, and media studies (especially social media).

Papers not directly related to the major theme but address any current issue on psychoactive substance use in Africa will be accepted for presentation at the conference. You will find below a list of suggested sub-themes and topics for your consideration.

Towards the Reform of Drug Law and Policy in Africa: Research, Practice and Advocacy Considerations

Availability of services for people who use drugs; access to treatment; drug markets in Africa; decriminalization of drug use; regulation of drugs; medicinal cannabis; harm reduction; availability of medications for the management of pain; control of prescription opioids; alcohol and tobacco policies; measuring policy effectiveness; assessment of national plans of action, and national practice guidelines; stigma; alternative development; role of the media and civil society; gender perspectives; drugs and the legal system; the current state of drug policy research, vulnerable populations; etc.

Venue: The conference will take place in Abuja at a venue to be determined later.

Please take note of the following important dates:

Abstract submission deadline: 17 June 2022

Full Paper submission deadline: 2 September 2022

Early Bird registration: 9 September 2022

Begin with the paper title followed by author(s), affiliation(s).

The first and last names of authors should be written in full.

Provide full contact information for the lead author.

The main body of the abstract should be in one paragraph with no subheadings for the sections.

Submit as a Word document to crisainfo1@gmail.com or info@crisaafrica.org.

More information on pre-conference workshops, registration, travel, accommodation, etc. will be available on the CRISA website (www.crisaafrica.org) in due course. You can also contact us directly for such information.

Registered participants will be served lunch and tea/coffee for two days and will also receive conference materials, complimentary copies of the 

African Journal of Drug and Alcohol Studies

, other publications, and certificates of participation.

Early registration (by 9 September): N35,000

For further information about the conference please contact:

Ms Gloria Akpabio, CRISA, 10 Okon Essien Close, Uyo, Nigeria

Email: crisainfo1@gmail.com or info@crisaafrica.org

Professor Isidore S. Obot, Executive Director, CRISA

Email: obotis@gmail.com or iobot@crisaafrica.org

Information about registration, travel and accommodation will also be available on the CRISA website — www.crisaafrica.org.

14th Biennial International Conference on Drugs, Alcohol and Society in Africa

Yong-an Zhang - International Center for Drug Policy Studies ICDPS, Shanghai University (Chair)

Khalid Tinasti CCDP, Geneva Graduate Institute (Switzerland) ICDPS, Shanghai University (Moderator)

Gloria Lai, International Drug Policy Consortium Asia (Thailand)

Luciana Pol, Centro de Estudos Legales y Sociales (Argentina)

Deborah Alimi, Paris University Panthéon-Sorbonne (France)

Adeolu Adebiyi, West Africa Commission on Drugs (Nigeria)

Nazlee Maghsoudi, University of Toronto (Canada)

2009-2019: Capturing a decade of international drug policy advocacy

: Oct 27, 10am - 12pm ET / 27 de oct 9am-11am Bogotá

Isabel Pereira, Deputy Director, Dejusticia; @Dejusticia_en @Dejusticia 

Santiago Tobón, Visiting Professor, University of Chicago; Professor, Economics, EAFIT; @SantiagoTobon @EAFIT 

María Alejandra Vélez, Director, Center for the Study of Security and Drugs, Universidad de los Andes; @MajaVelez @CesedUniandes 

Ana Arjona, Associate Professor, Northwestern University; @anamarjona @PoliSciatNU @redesdal 

Ken Frankel, President, Canadian Council for the Americas; @knfrankel @CCACANADA

Events